{"disease":{"id":"benign-intracranial-hypertension","name":"Benign intracranial hypertension","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"mannitol-20","indication_name":"Benign intracranial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mannitol","generic_name":"Mannitol","company_name":"Baxter","drug_phase":"marketed","molecular_target":"Glomerular filtrate osmolarity; intracellular water movement","drug_class":"Osmotic diuretic","quality_score":66,"revenue":null,"mechanism":"Osmotic diuretic that elevates glomerular filtrate osmolarity to inhibit tubular water reabsorption."},{"drug_id":"mannitol","indication_name":"Benign intracranial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aridol Kit","generic_name":"MANNITOL","company_name":"Baxter","drug_phase":"marketed","molecular_target":"sodium channels","drug_class":"Osmotic Diuretic [EPC]","quality_score":75,"revenue":null,"mechanism":"Mannitol works by drawing water into the bloodstream from surrounding tissues, increasing urine production and reducing fluid accumulation in the body."},{"drug_id":"thiopental","indication_name":"Benign intracranial hypertension","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pentothal","generic_name":"THIOPENTAL","company_name":"Abbott","drug_phase":"marketed","molecular_target":"GABA-A receptor alpha-1/beta-2/gamma-2","drug_class":"thiopental","quality_score":30,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04032379","title":"Diagnostic and Prognostic Biomarkers of Idiopathic Intracranial Hypertension","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Danish Headache Center","has_results":false}],"total":1},"guidelines":[{"drug_id":"mannitol-20","guideline_body":"FDA label","recommendation":"OSMITROL is indicated for the reduction of intracranial pressure.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"mannitol-20","guideline_body":"FDA label","recommendation":"OSMITROL is indicated for the reduction of intracranial pressure and treatment of cerebral edema.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"mannitol-25","guideline_body":"FDA label","recommendation":"OSMITROL is indicated for the reduction of intracranial pressure.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"mannitol-5","guideline_body":"FDA label","recommendation":"OSMITROL is indicated for the reduction of intracranial pressure.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"mannitol-10","guideline_body":"FDA label","recommendation":"OSMITROL is indicated for the reduction of intracranial pressure.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null}],"source":"Drug Landscape verified database"}